Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Vistagen Therapeutics (VTGN) reported Return on Capital Employed [ROCE] of -286.29% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 179.45 percentage points from -106.84% a year earlier and down 61.26 percentage points from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics posted Return on Capital Employed [ROCE] of -134.42%, down 73.17 percentage points from FY2025.

  • Return on Capital Employed [ROCE] has a five-year change of -100.48 percentage points (FY2021 to FY2026).
  • By fiscal year, Return on Capital Employed [ROCE] came in at -61.25% in FY2025 (-12.15 pp), -49.10% in FY2024 (+87.80 pp), -136.90% in FY2023 (-81.15 pp) and -55.75% in FY2022 (-21.81 pp).
  • The fiscal Q2 2027 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] since fiscal Q1 2024.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last eight quarters, with an average year-over-year change of -80.66 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was fiscal Q1 2025 (a gain of 297.86 percentage points); the low point was fiscal Q1 2024 (a drop of 228.28 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -225.03% (Q1 2027), -163.85% (Q4 2026) and -117.55% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -5,780.97%
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 35.41%
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 17.52%
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 21.60%
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 4.65%
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 17.37%
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -6.15%
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - -286.29%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -286.29%
Jun 30, 2026 -225.03%
Mar 31, 2026 -163.85%
Dec 31, 2025 -117.55%
Sep 30, 2025 -106.84%
Jun 30, 2025 -91.09%
Mar 31, 2025 -73.93%
Dec 31, 2024 -60.19%
Sep 30, 2024 -45.37%
Jun 30, 2024 -33.96%
Mar 31, 2024 -27.01%
Dec 31, 2023 -41.11%
Sep 30, 2023 -139.21%
Jun 30, 2023 -331.82%
Mar 31, 2023 -284.60%
Dec 31, 2022 -206.10%
Sep 30, 2022 -147.69%
Jun 30, 2022 -103.54%
Mar 31, 2022 -62.19%
Dec 31, 2021 -41.87%
API Access

Vistagen Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEY